Penserra Capital Management LLC Vyne Therapeutics Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.91 - $1.5 $1,078 - $1,777	-1,185 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.39 - $3.47 $20 - $52	15 Added 1.28%	1,185 $1,000
Q2 2021 Aug 12, 2021	BUY	$3.24 - $6.92 $16 - $34	5 Added 0.43%	1,170 $4,000
Q1 2021 May 13, 2021	BUY	$6.34 - $12.68 $7,386 - $14,772	1,165 New	1,165 $7,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $176M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.